Navigation Links
Novadaq to present at BMO Healthcare Conference
Date:11/28/2007

cence which allows surgeons to differentiate between healthy and cancerous tissue in the lung during thoracic surgery. Novadaq is also the exclusive United States distributor of PLC Medical's CO(2) HEART LASER(TM) System for TMR (Trans-Myocardial Revascularization). For more information, please visit the company's website at http://www.novadaq.com.

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Novadaq's current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, the market entry (and timing thereof) of additional suppliers of ICG, market acceptance and future commitments for the PINPOINT endoscopic imaging system and other Novadaq devices. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings; actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Novadaq Technologies Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
2. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
3. Novadaq announces third quarter 2007 conference call and webcast
4. Novadaq to present at Piper Jaffray Healthcare Conference
5. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
6. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
7. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
8. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
10. AtriCure to Present at Roth Capital Partners 2007 New York Conference
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...to condemn hurtful comments, study suggests , ... people overestimate how strongly they would react...Sixty-three percent of study participants at York ... an experiment with a white person rather than a b...comments about the black person when he left the r...
(Date:1/8/2009)... Jan. 8 Hanger Orthoped...ce that throughout the fourth quarter of 2008 it a...r, Rocky Mountain Orthotic-Prosthetics Center, Rie...irst Coast Orthotics & Prosthetics, and Orthop...ons add patient care centers to existing markets i...
(Date:1/8/2009)...Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Internati...any"), a leading independent American,provider of...eople,s Republic,of China, today announced that t... Conference, to be held in Shanghai on January 12t...nference will be held at the Pudong Shangri-,La h...
(Date:1/8/2009)...an. 8 Cephalon, Inc . (...o, Jr., Ph.D., Chairman and CEO will present at t...n January 13, 2009 in San Francisco, CA at approxi...). The presentation will be webcast live on the in... , , The webcast will be archived for one week...
Breaking Medicine News(10 mins):Health News:Many Turn Blind Eye to Racism 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...herapy -- a chemical treatment to remove lead from... behavioral problems that result from lead exposur..., in a further finding that has implications for t...e researchers say that when rats with no lead in t...
...ducted on women in their 70's to observe the relat...n older women. This study followed nearly 12,000 ...ding reports that moderate alcohol intake (1-2 dri...content) may lead to increased quality of life and...
...an’s heart is through his stomach, they say! Is th...chen? Food for thought, of course! Meanwhile, what...equently good health? Grab the attention of the la...esearchers from Newcastle University’s Human Nutri...
...d of the Delhi government will investigate the cas...ated //upon for congenital hernia instead of an ex...ijpal was taken to a wrong operation theatre Tuesd..., where he had been admitted for removing the sixt...
Other Medicine News:Health News:Pros and Cons of Therapy for Lead Exposure 2Health News:How a Woman Holds Fort in Her Little Kingdom – The Kitche 2
(Date:1/6/2009)...r maintaining a healthy immune system , , PURCH...shed study in Nutrition and Cancer (60(5), 643-6... Osaka, Japan has shown that AHCC (Active Hexose C...creasing the number of dendritic cells (DCs). DCs ...r presenting foreign substances to other immune sy...
(Date:1/6/2009)...wswire/ -- Cequent Pharmaceuticals, a pioneer in t...ased treatments to prevent and treat human disease...d a successful toxicology study of its candidate C... targeting the primary oncogene (beta-catenin, CTN...is an inherited gastrointestinal disease that caus...
(Date:1/5/2009)...ewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: M...l, proprietary,antibodies for the treatment of ca...des an outlook on key events anticipated for the y...n update on its research and development,programs...16, 2009: Update on several preclinical BiTE antib...
(Date:12/29/2008)...wire-USNewswire/ -- The winner of the 2008 Award f...ounced today by Dr. Peter G. Goldschmidt, Presiden... , , The winner of the annual award was the ...-- for its best practice " IND Regulatory and Mo...nhanced human subjects protection, 2) improved dat...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2Depressed Moms Kids at Higher Injury Risk 7613 1Depressed Moms Kids at Higher Injury Risk 7613 2Fry Construction Is Featured in Key Industry Publication 7610 1Fry Construction Is Featured in Key Industry Publication 7610 2InvoiceCHECK Cuts Prescription Benefit Waste 7606 1InvoiceCHECK Cuts Prescription Benefit Waste 7606 2DenteMax Forms Business Alliance With MEDILINQ 7602 1DenteMax Forms Business Alliance With MEDILINQ 7602 2
...lood Pressure in Obese and,Non-Obese Hypertensive ...all/ -- Forest,Laboratories, Inc. today presented ...oled analysis of nebivolol, a selective beta,1-blo...review by,the U.S. Food and Drug Administration (F...he two clinical studies show that,nebivolol demons...
... and 40/25 mg/day and Amlodipine +,Benazepril 5/20...,Hypertension Twenty-Second Annual Scientific Meet...- New data,presented today at the American Society... Meeting (ASH 2007) in Chicago,demonstrated that t...medoxomil/hydrochlorothiazide) was associated with...
Other Medicine Technology:Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
...tome Semi-Automatic Tissue Sectioning System has m...ctioning system. Researchers from around the globe...ir fresh and fresh fixed tissue sectioning needs f...issue Sectioning Systems, the biological viability...
...3000 Deluxe Sectioning System provides a versatile...ant tissues. The 3000 employs a vibrating blade p...or embedding. The creation of artifacts, the alte...tivities, and other deleterious effect inherent in...
The Vibratome comes standard with a square vice mounting device. These specimen blocks are utilized for mounting specimens and placing in the Vibratome holding vice. The blocks are annodized black
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
Medicine Products: